BHVN (Biohaven) PB Ratio: 180.74 (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BHVN Biohaven Ltd BHVN
32 GF Score
Price $14.64
! 2 Warning Signs
View Full Analysis

What is Biohaven PB Ratio?

Biohaven BHVN -1.41% 32 PB Ratio is 180.74 as of Aug. 16, 2026. GuruFocus rates BHVN with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 1,220 Biotechnology companies, Biohaven ranks worse than 99.18% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-16), Biohaven's share price is $14.64. Biohaven's Book Value per Share for the quarter that ended in Jun. 2026 was $0.08. Hence, Biohaven's PB Ratio of today is 180.74.

The historical rank and industry rank for Biohaven's PB Ratio or its related term are showing as below:

BHVN' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 180.74
Current: 180.74

During the past 6 years, Biohaven's highest PB Ratio was 180.74. The lowest was 0.00. And the median was 0.00.

BHVN's PB Ratio is ranked worse than
99.18% of 1220 companies
in the Biotechnology industry
Industry Median: 2.88 vs BHVN: 180.74

During the past 12 months, Biohaven's average Book Value Per Share Growth Rate was -90.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -63.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 9.30% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Biohaven was 124.20% per year. The lowest was -63.30% per year. And the median was 62.90% per year.

Back to Basics: PB Ratio


Biohaven  (NYSE:BHVN) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Biohaven PB Ratio Related Terms


Biohaven PB Ratio Historical Data

* Premium members only.

The historical data trend for Biohaven's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biohaven PB Ratio Chart

Biohaven Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial 0.00 1.76 8.11 8.93 28.80

Biohaven Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.09 0.00 28.80 9.84 183.70

BHVN vs AGIO, VRDN, ZLAB: PB Ratio Comparison

For the Biotechnology subindustry, Biohaven's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biohaven PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biohaven's PB Ratio distribution charts can be found below:

* The bar in red indicates where Biohaven's PB Ratio falls into.


BHVN
32GF Score
Biohaven Ltd BHVN
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biohaven PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Biohaven's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2026)
=14.64/0.081
=180.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 180.74 mean?
Biohaven (BHVN) has a PB Ratio of 180.74 as of Aug. 16, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Biohaven and its competitors. According to the industry distribution chart, Biohaven ranks #1210 out of 1220 companies in the Biotechnology industry, placing it in the top 99.2%.
Is Biohaven's PB Ratio too high?
Biohaven's current PB Ratio is 180.74. The Biotechnology industry median PB Ratio is 2.88. Biohaven's value of 180.74 is 6175.7% above this industry median. Based on the distribution chart, Biohaven ranks #1210 out of 1220 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Biohaven has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Biohaven's PB Ratio compare to AGIO and VRDN?
According to the Biotechnology industry distribution chart, Biohaven ranks #1210 out of 1220 companies for PB Ratio. This places Biohaven in the lower half of its industry. The industry median PB Ratio is 2.88. Biohaven's value of 180.74 is 6175.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.88, based on 1,220 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biohaven's current PB Ratio of 180.74 is 6175.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Biohaven and its competitors. For the Biotechnology industry, the median PB Ratio is 2.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biohaven's current PB Ratio is 180.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biohaven stock overvalued right now?
Biohaven (BHVN) has a current PB Ratio of 180.74. The current PB Ratio is 180.74 and 6175.7% above the Biotechnology industry median of 2.88. Biohaven's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Biohaven (BHVN), the current PB Ratio is 180.74 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biohaven Business Description

Other Exchanges BHVN34:Brazil
Address c/o Biohaven Pharmaceuticals, Inc, 215 Church Street, New Haven, CT, USA, 06510
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
32GF Score

Get the complete analysis for BHVN

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.64
Price